Presente y futuro del tratamiento farmacol�gico de la vejiga hiperactiva

Mu�oz G�lligo, E.; Garc�a Garc�a-Porrero, A.; Masero Casasola, A. R.; Mu�oz Garrido, F.
December 2012
Suelo P�lvico;2012, Vol. 8 Issue 3, p64
Academic Journal
The overactive bladder syndrome has a complex physiopathological basis, which implies muscular and neural systems and a complex array of molecular intermediaries. In fact, in our days the pharmacological treatment, based on anticholinergics drugs, is not effective in a great proportion of patients. In our review we explain the physiopathological basis, remarking the role of the therapeutical targets as an aim of the new drugs that are being investigated. Between the pharmacological families we found the betaagonists, as a new option of treatment. In any case, there are other many options being investigated, and we need more data before they can reach a clinical utility.


Related Articles

  • Flavoxate: present and future. ARCANIOLO, D.; CONQUY, S.; TARCAN, T. // European Review for Medical & Pharmacological Sciences;Mar2015, Vol. 19 Issue 5, p719 

    OBJECTIVE: This non-systematic review discusses the available evidence on the use of flavoxate in the treatment of overactive bladder (OAB). METHODS: Medline was searched for inclusion of relevant studies. No limitations in time were considered. RESULTS: Flavoxate hydrochloride is an...

  • Trospium.  // AHFS Consumer Medication Information;Apr2018, p1 

    Trospium is used to treat an overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Trospium is in a class of medications called anticholinergics. It works by relaxing the...

  • ASTHMA TREATMENTS: INHALATIONS.  // Monthly Prescribing Reference;Jun2014, Vol. 30 Issue 6, p300 

    The article evaluates several inhalation drugs for asthma treatment including ant cholinergic ipratropium bromide, β2-agonist levalbuterol hydrochloric acid (HCl) and steroid budesonide.

  • Do Children with Acute Asthma Benefit More from Anticholinergics and Beta2 Agonists than from Beta2 Agonists Alone? CLEARY-HAMMARSTEDT, CASEY; FLYNN, CHERYL A. // American Family Physician;2015 Special Issue, Vol. 91, p1 

    The article discusses a study on the therapeutic and adverse effects of adding inhaled anticholinergics to beta2 agonists in the treatment of acute pediatric asthma. Topics covered include group differences in lung function supporting combination therapy with anticholinergics and beta2 agonists,...

  • A new option for people living with overactive bladders.  // Asian Pacific Post;5/23/2013, p7 

    The article offers information on various treatment options for overactive bladder (OAB).

  • Sacral Neuromodulation Causes Few Serious AEs.  // Renal & Urology News;Oct2016, Vol. 15 Issue 8, p11 

    The article highlights the result of research study that suggests overactive bladder patients undergoing sacral neuromodulation therapy with the InterStim System have a 30% rate of reported device-related adverse events after 1 year.

  • Or Is It Just a Little Relaxation? Govil, Yogesh K.; Katz, Philip O. // American Journal of Gastroenterology;May2001, Vol. 96 Issue 5, p1638 

    Lagergren et al. performed a population-based, case-control study to investigate the possible association between use of lower esophageal sphincter (LES)-relaxing medications and risk for adenocarcinoma of the esophagus, squamous cell cancer of the esophagus, and adenocarcinoma of the...

  • A Case-Based Approach for Overactive Bladder to Evaluate and Implement Successful Treatment Strategies. Ellsworth, Pamela // Journal of Managed Care Medicine;2014, Vol. 17 Issue 1, p10 

    No abstract available.

  • Still cause for concern. Tattersfield, A.E. // BMJ: British Medical Journal (International Edition);9/24/94, Vol. 309 Issue 6957, p794 

    Focuses on the use of beta agonist on patients with asthma in the Great Britain. Mortality rate in the year 1960s and 1970s; Implication of high dosage of beta agonists on mortality rate from asthma; Suggestion of the morbidity study on the tolerance of beta agonist among asthma patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics